SCHEMBL2038643

SCHEMBL2038643

Cc1cc(NCc2ccc(F)cc2O)cc(Br)n1

nearest known ligand 0.43

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MAP2K4 P45985 1/20 0.43
CASP6 P55212 15/20 0.43
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
KMT2A Q03164 1/20 0.41
PLEC Q15149 1/20 0.41
PDE2A O00408 1/20 0.40
MAOB P27338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2039704 0.91 KMT2A (0.43) MEN1ALDH1A1POLBMAPTKMT2A
SCHEMBL2038649 0.84 MAP2K4 (0.41) MAP2K4CASP6MEN1ALDH1A1POLB
SCHEMBL2044460 0.83 MAPT (0.55) MEN1ALDH1A1MAPTKMT2AMAOB
SCHEMBL2042919 0.75 MEN1 (0.41) MEN1ALDH1A1POLBMAPTKMT2A
SCHEMBL2041507 0.74 KMT2A (0.42) MEN1ALDH1A1MAPTKMT2AMAOB
SCHEMBL2043884 0.72 MEN1 (0.46) MAP2K4CASP6MEN1ALDH1A1POLB
SCHEMBL2040736 0.70 L3MBTL1 (0.43) MAP2K4CASP6MEN1ALDH1A1POLB
SCHEMBL2038199 0.69 KDM4E (0.46) CASP6MEN1ALDH1A1POLBMAPT
SCHEMBL2044273 0.68 NOX4 (0.49) MEN1ALDH1A1MAPTKMT2A
SCHEMBL21494282 0.67 SLC6A4 (0.47) MAP2K4CASP6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10202346-B2 Phenol derivatives and the pharmaceutical or cosmetic use thereof GALDERMA RESEARCH & DEVELOPMENT (FR) 2019-02-12 US claimed
US-20130178633-A1 PHENOL DERIVATIVES AND THE PHARMACEUTICAL OR COSMETIC USE THEREOF GALDERMA RESEARCH & DEVELOPMENT (FR) 2013-07-11 US claimed
US-10202346-B2 Phenol derivatives and the pharmaceutical or cosmetic use thereof GALDERMA RESEARCH & DEVELOPMENT (FR) 2019-02-12 US disclosed
EP-2516400-B1 PHENOL DERIVATIVES AND THE PHARMACEUTICAL OR COSMETIC USE THEREOF GALDERMA RES & DEV (FR) 2017-03-22 EP disclosed
US-20160068488-A1 PHENOL DERIVATIVES AND THE PHARMACEUTICAL OR COSMETIC USE THEREOF COLLETTE PATRICE LUCIEN MAURICE (FR) 2016-03-10 US disclosed
US-20130178633-A1 PHENOL DERIVATIVES AND THE PHARMACEUTICAL OR COSMETIC USE THEREOF GALDERMA RESEARCH & DEVELOPMENT (FR) 2013-07-11 US disclosed
EP-2516400-A1 PHENOL DERIVATIVES AND THE PHARMACEUTICAL OR COSMETIC USE THEREOF Galderma Research & Development (FR) 2012-10-31 EP disclosed
WO-2011077046-A1 PHENOL DERIVATIVES AND THE PHARMACEUTICAL OR COSMETIC USE THEREOF GALDERMA RESEARCH & DEVELOPMENT (FR) 2011-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160068488-A1 PHENOL DERIVATIVES AND THE PHARMACEUTICAL OR COSMETIC USE THEREOF TYR, MITF, CUTA MAP2K4 2865/4885CASP6 2039/4885MEN1 3059/4885
US-20130178633-A1 PHENOL DERIVATIVES AND THE PHARMACEUTICAL OR COSMETIC USE THEREOF TYR, MITF, CUTA MAP2K4 2865/4885CASP6 2039/4885MEN1 3059/4885
US-10202346-B2 Phenol derivatives and the pharmaceutical or cosmetic use thereof TYR, MITF, CUTA MAP2K4 2865/4885CASP6 2039/4885MEN1 3059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.